ACETAMINOPHEN (acetaminophen) by Gland Pharma is 12. First approved in 1980.
Drug data last refreshed 10h ago · AI intelligence enriched 1w ago
Acetaminophen is a widely-used analgesic and antipyretic small molecule indicated for pain relief and fever reduction across multiple patient populations. The precise mechanism remains incompletely understood but is thought to involve central nervous system actions. It is available in multiple formulations including rectal suppository, with a well-established safety and efficacy profile in both adults and pediatric patients.
As loss of exclusivity approaches, brand teams face significant generic erosion; roles focus on maximizing remaining revenue through market share defense and formulation differentiation.
12.1 Mechanism of Action The precise mechanism of the analgesic and antipyretic properties of acetaminophen is not established but is thought to primarily involve central actions. 12.2 Pharmacodynamics Acetaminophen has been shown to have analgesic and antipyretic activities in animal and human…
Worked on ACETAMINOPHEN at Gland Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
A Multiple-Dose Safety Study of Fixed Combination of Acetaminophen/Naproxen Sodium in Adolescents With Orthodontic Pain
A Study of Acetaminophen/Naproxen Sodium Fixed Combination Tablets in Adolescents 12 to <17 Years of Age With Pain
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on acetaminophen as a mature, genericized product offers limited career growth and is typically reserved for professionals focused on operational efficiency, defensive marketing, and cost management. Positions are fewer in number and offer less prestige than roles on branded growth-stage products, but provide stability in a well-understood therapeutic area.